Cantor Fitzgerald, L. P. Renalytix PLC Transaction History
Cantor Fitzgerald, L. P.
- $697 Million
- Q2 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Renalytix PLC stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 115,000 shares of RNLX stock, worth $29,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115,000Holding current value
$29,900% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.72MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD815KShares$212,0100.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$145,8600.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$144,3000.01% of portfolio
-
Tejara Capital LTD London, X0500KShares$130,1020.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$87,2330.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $9.74M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...